The Lymphocyte-to-Monocyte Ratio (LMR) as a Novel Biomarker for Cervical Cancer Risk Stratification in Conization Patients

<b>Background:</b> Cervical cancer remains a major global health burden, particularly in regions with limited early detection. The Loop Electrosurgical Excision Procedure (LEEP) is commonly used to diagnose and treat cervical intraepithelial neoplasia (CIN). The lymphocyte-to-monocyte ratio (LMR) is a potential biomarker for cancer risk stratification. It reflects immune function and tumor-related inflammation. Lower LMR values suggest reduced antitumor immunity and increased tumor-promoting inflammation, which are linked to cancer development and progression. This study examines relationships between preoperative LMR and histopathological outcomes after LEEP. <b>Methods:</b> This retrospective study included 374 patients undergoing the LEEP for cervical dysplasia. Preoperative LMR values were compared across four histopathological categories: negative, low-grade, high-grade lesions, and invasive carcinoma. The Kruskal-Wallis test assessed group differences, with Mann-Whitney U tests for pairwise comparisons. ROC curve analysis (<i>n</i> = 369) evaluated LMR's diagnostic performance, and logistic regression evaluated its independent predictive value. <b>Results:</b> LMR significantly differed across cytological (<i>p</i> = 0.04) and histological groups (<i>p</i> = 0.036). Post hoc analysis revealed significantly lower LMR in invasive carcinoma versus low-grade lesions in cytology and for both low- and high-grade lesions in histology. ROC analysis yielded an AUC of 0.680. An LMR cutoff <4.49 showed 82.6% sensitivity and 50.0% specificity. Stricter cutoff (<3.89) increased specificity (66.8%) but decreased sensitivity (60.9%). Both had high negative predictive values (97.7% and 96.2%) but low positive predictive values (9.9% and 10.9%). <b>Conclusions:</b> LMR may serve as a complementary biomarker to predict higher-grade cervical lesions and help rule out invasive disease, aiding patient triage in resource-limited settings.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2025-08-27
DOI
https://doi.org/10.3390/jcm14176057
Citations
3
Primary Topic
Endometrial and Cervical Cancer Treatments
Type
article
Field-Weighted Citation Impact
6.17
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Lymphocyte-to-Monocyte Ratio (LMR) as a Novel Biomarker for Cervical Cancer Risk Stratification in Conization Patients

Márton Keszthelyi, Attila Keszthelyi, Nándor Ács, Petra Merkely et al.
3 citations
Journal of Clinical Medicine
Endometrial and Cervical Cancer Treatments
6.17
article

The Lymphocyte-to-Monocyte Ratio (LMR) as a Novel Biomarker for Cervical Cancer Risk Stratification in Conization Patients

Márton Keszthelyi, Attila Keszthelyi, Nándor Ács, Petra Merkely, V. Szabó, Lotti Lőczi, Balázs Lintner, Szabolcs Várbı́ró, Richárd Tóth, Zsófia Tóth, Balázs Vida, Barbara Sebők, Noémi Kalas
article en
3 citations

Abstract

<b>Background:</b> Cervical cancer remains a major global health burden, particularly in regions with limited early detection. The Loop Electrosurgical Excision Procedure (LEEP) is commonly used to diagnose and treat cervical intraepithelial neoplasia (CIN). The lymphocyte-to-monocyte ratio (LMR) is a potential biomarker for cancer risk stratification. It reflects immune function and tumor-related inflammation. Lower LMR values suggest reduced antitumor immunity and increased tumor-promoting inflammation, which are linked to cancer development and progression. This study examines relationships between preoperative LMR and histopathological outcomes after LEEP. <b>Methods:</b> This retrospective study included 374 patients undergoing the LEEP for cervical dysplasia. Preoperative LMR values were compared across four histopathological categories: negative, low-grade, high-grade lesions, and invasive carcinoma. The Kruskal-Wallis test assessed group differences, with Mann-Whitney U tests for pairwise comparisons. ROC curve analysis (<i>n</i> = 369) evaluated LMR's diagnostic performance, and logistic regression evaluated its independent predictive value. <b>Results:</b> LMR significantly differed across cytological (<i>p</i> = 0.04) and histological groups (<i>p</i> = 0.036). Post hoc analysis revealed significantly lower LMR in invasive carcinoma versus low-grade lesions in cytology and for both low- and high-grade lesions in histology. ROC analysis yielded an AUC of 0.680. An LMR cutoff <4.49 showed 82.6% sensitivity and 50.0% specificity. Stricter cutoff (<3.89) increased specificity (66.8%) but decreased sensitivity (60.9%). Both had high negative predictive values (97.7% and 96.2%) but low positive predictive values (9.9% and 10.9%). <b>Conclusions:</b> LMR may serve as a complementary biomarker to predict higher-grade cervical lesions and help rule out invasive disease, aiding patient triage in resource-limited settings.

Journal of Clinical MedicineVol. 14(17)
Semmelweis University (HU), University of Szeged (HU)
Openalex Percentile: Top 4%
Endometrial and Cervical Cancer Treatments
6.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.